Efficacy and Safety of Dapagliflozin in Children With Proteinuria

Clinical trial NCT07204743 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07204743
Sponsor: Al-Quds University
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

SGLT 2 Inhibitors Pediatric Kidney Disease Proteinuric Diseases Dapagliflozin (Forxiga)

Start date: 2025-08-15
Primary completion: 2026-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.